Since the knock‐down KRAS have the capacity to inhibit cellular homeostatic survival in cancer cells, the knock‐down KRAS HCC cell (SMMC‐7721) also exhibits low glycolytic metabolism (Figure 6B). This evidence concerns the gene KRAS and hepatocellular carcinoma.